Comments
Loading...
Abbott Laboratories Earnings Estimates, EPS & Revenue | NYSE:ABT | Benzinga
Abbott Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 16
EPS Estimate
$1.110
Quarterly Revenue Estimate
$10.67B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$41.95B
Analyze the earnings history of Abbott Laboratories using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $0.98 | $1.11 | — | — | $9.96B | $10.67B | — | — | 04/16/2025 | Get Alert |
| ABT | Abbott Laboratories | $1.19 | $1.34 | $1.34 | 0.00% | $10.24B | $11.03B | $10.97B | -0.51% | 01/22/2025 | Get Alert |
| ABT | Abbott Laboratories | $1.14 | $1.20 | $1.21 | 0.83% | $10.14B | $10.55B | $10.63B | 0.81% | 10/16/2024 | Get Alert |
| ABT | Abbott Laboratories | $1.08 | $1.10 | $1.14 | 3.64% | $9.98B | $10.37B | $10.38B | 0.07% | 07/18/2024 | Get Alert |
| ABT | Abbott Laboratories | $1.03 | $0.95 | $0.98 | 3.16% | $9.75B | $9.88B | $9.96B | 0.85% | 04/17/2024 | Get Alert |
| ABT | Abbott Laboratories | $1.03 | $1.19 | $1.19 | 0.00% | $10.09B | $10.18B | $10.24B | 0.60% | 01/24/2024 | Get Alert |
| ABT | Abbott Laboratories | $1.15 | $1.04 | $1.14 | 9.62% | $10.41B | $9.32B | $10.14B | 8.83% | 10/18/2023 | Get Alert |
| ABT | Abbott Laboratories | $1.43 | $1.05 | $1.08 | 2.86% | $11.26B | $9.70B | $9.98B | 2.87% | 07/20/2023 | Get Alert |
| ABT | Abbott Laboratories | $1.73 | $0.99 | $1.03 | 4.04% | $11.89B | $9.64B | $9.75B | 1.11% | 04/19/2023 | Get Alert |
| ABT | Abbott Laboratories | $1.32 | $0.92 | $1.03 | 11.96% | $11.47B | $9.64B | $10.09B | 4.68% | 01/25/2023 | Get Alert |
| ABT | Abbott Laboratories | $1.40 | $0.94 | $1.15 | 22.34% | $10.93B | $9.64B | $10.41B | 7.99% | 10/19/2022 | Get Alert |
| ABT | Abbott Laboratories | $1.17 | $1.12 | $1.43 | 27.68% | $10.22B | $10.29B | $11.26B | 9.40% | 07/20/2022 | Get Alert |
| ABT | Abbott Laboratories | $1.32 | $1.47 | $1.73 | 17.69% | $10.46B | $11.02B | $11.89B | 7.94% | 04/20/2022 | Get Alert |
| ABT | Abbott Laboratories | $1.45 | $1.21 | $1.32 | 9.09% | $10.70B | $10.71B | $11.47B | 7.08% | 01/26/2022 | Get Alert |
| ABT | Abbott Laboratories | $0.98 | $0.94 | $1.40 | 48.94% | $8.85B | $9.54B | $10.93B | 14.55% | 10/20/2021 | Get Alert |
| ABT | Abbott Laboratories | $0.57 | $1.02 | $1.17 | 14.71% | $7.33B | $9.69B | $10.22B | 5.50% | 07/22/2021 | Get Alert |
| ABT | Abbott Laboratories | $0.65 | $1.27 | $1.32 | 3.94% | $7.73B | $10.69B | $10.46B | -2.19% | 04/20/2021 | Get Alert |
| ABT | Abbott Laboratories | $0.95 | $1.35 | $1.45 | 7.41% | $8.31B | $9.94B | $10.70B | 7.66% | 01/27/2021 | Get Alert |
| ABT | Abbott Laboratories | $0.84 | $0.90 | $0.98 | 8.89% | $8.08B | $8.51B | $8.85B | 4.03% | 10/21/2020 | Get Alert |
| ABT | Abbott Laboratories | $0.82 | $0.41 | $0.57 | 39.02% | $7.98B | $6.75B | $7.33B | 8.56% | 07/16/2020 | Get Alert |
| ABT | Abbott Laboratories | $0.63 | $0.58 | $0.65 | 12.07% | $7.54B | $7.34B | $7.73B | 5.26% | 04/16/2020 | Get Alert |
Abbott Laboratories (ABT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-22 | $1.34 | $1.34 | 0.00 % |
| Q3 | 2024-10-16 | $1.21 | $1.20 | 0.83 % |
| Q2 | 2024-07-18 | $1.14 | $1.10 | 3.64 % |
| Q1 | 2024-04-17 | $0.98 | $0.95 | 3.16 % |
Abbott Laboratories (ABT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-22 | $10.97B | $11.03B | -0.51 % |
| Q3 | 2024-10-16 | $10.64B | $10.55B | 0.81 % |
| Q2 | 2024-07-18 | $10.38B | $10.37B | 0.07 % |
| Q1 | 2024-04-17 | $9.96B | $9.88B | 0.85 % |
FAQ
When is Abbott Laboratories (NYSE:ABT) reporting earnings?
Abbott Laboratories (ABT) is scheduled to report earnings on April 16, 2025. The last reported earnings were for reported on January 22, 2025 for Q4.
What were the latest earnings per share (EPS) for Abbott Laboratories (NYSE:ABT)?
The Actual EPS was $1.34, which hit the estimate of $1.34.
What were Abbott Laboratories’s (NYSE:ABT) revenues?
The Actual Revenue was $11B, which missed the estimate of $11B.
Browse earnings estimates, EPS, and revenue on all stocks.